Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste Assessment of Suzetrigine SDD in Healthy Adults
NCT06834009Phase 1Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of suzetrigine in acute pain and neuropathic pain, sponsored by Vertex Pharmaceuticals. Primary endpoint: Flavor Assessment Based on Flavor Profile Method of Descriptive Sensory Analysis up to 30 minutes. Started Mar 2025; status: completed.
02
Drugs
suzetrigine
03
Conditions
acute painneuropathic pain
Beyond the preview
Go deeper on NCT06834009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834009.